NCT ID | NCT01757327 |
Title | LDE225 in Treating Patients With Stage II-III Estrogen Receptor- and HER2-Negative Breast Cancer |
Recruitment | Withdrawn |
Gender | female |
Phase | Phase II |
Variant Requirements | yes |
Sponsors | Washington University School of Medicine |
Indications | |
Therapies | |
Age Groups: | adult |